Hemodialysis access thrombosis

Keith Bertram Quencer, Rahmi Oklu

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


For the over 400,000 patients in the United States dependent on hemodialysis, arteriovenous (AV) access thrombosis may lead to missed dialysis sessions, inpatient admissions and the need for placement of temporary dialysis catheters. It is also the leading cause of permanent access loss. Percutaneous declotting is generally preferred over surgical thrombectomy. Various percutaneous approaches can be employed including the lyse-and-wait technique, thromboaspiration, pulse spray aided pharmacomechanical thrombolysis, and use of mechanical thrombectomy device.

Original languageEnglish (US)
Pages (from-to)S299-S308
JournalCardiovascular Diagnosis and Therapy
StatePublished - Dec 1 2017


  • AV access thrombosis
  • Arteriovenous fistula (AVF)
  • Arteriovenous graft (AVG)
  • Pulse spray aided pharmacomechanical thrombolysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Hemodialysis access thrombosis'. Together they form a unique fingerprint.

Cite this